Curcumae Rhizoma - combined with Sparganii Rhizoma in the treatment of liver cancer: Chemical analysis using UPLC-LTQ-Orbitrap MSn, network analysis, and experimental assessment

Objective:Curcumae Rhizoma–Sparganii Rhizoma (CR-SR) is a traditional botanical drug pair that can promote blood circulation, remove blood stasis, and treat tumors in clinics. The aim of the present study was to investigate the therapeutic material basis and potential mechanisms of CR-SR, CR, and SR...

Descripció completa

Dades bibliogràfiques

Autors principals:	Jing Wei, Xiaoping Wang, Ying Dong, Xiangjian Zhong, Xueyang Ren, Ruolan Song, Jiamu Ma, Axiang Yu, Qiqi Fan, Jianling Yao, Dongjie Shan, Fang Lv, Yuan Zheng, Qingyue Deng, Xianxian Li, Yingyu He, Shusheng Fan, Chongjun Zhao, Xiuhuan Wang, Ruijuan Yuan, Gaimei She
Format:	Artigo
Idioma:	Inglês
Publicat:	Frontiers Media S.A. 2022-12-01
Col·lecció:	Frontiers in Pharmacology
Matèries:	Curcumae Rhizoma - Sparganii Rhizoma liver cancer molecular networking UPLC-LTQ-Orbitrap MSn zebrafish xenograft model
Accés en línia:	https://www.frontiersin.org/articles/10.3389/fphar.2022.1027687/full
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!